Endocrinologia

M-A | Efetividade das intervenções de manutenção de peso para adultos atendidos na atenção primária.

2 Jun, 2022 | 14:08h

Effectiveness of weight management interventions for adults delivered in primary care: systematic review and meta-analysis of randomised controlled trials – The BMJ

Comentário das autoras: Weight loss advice from GPs really can help people slim down and stay that way – new research – The Conversation

---

M-A | Efeitos do jejum intermitente comparados com dieta sem intervenção e restrição calórica.

31 Mai, 2022 | 12:32h

Effects of Intermittent Fasting in Human Compared to a Non-intervention Diet and Caloric Restriction: A Meta-Analysis of Randomized Controlled Trials – Frontiers in Nutrition

Conteúdos relacionados:

Time-Restricted Eating: Integrating The What With The When – Advances in Nutrition

Calorie Restriction with or without Time-Restricted Eating in Weight Loss- New England Journal of Medicine (link para o resumo – $ para o texto completo)

Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials – JAMA Network Open

---

Estudo randomizado | Consumo de uma dose pequena de whey protein antes da refeição, 3 vezes/dia, aumenta o tempo de euglicemia durante 7 dias em indivíduos com diabetes tipo 2.

31 Mai, 2022 | 12:10h

Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes – BMJ Open Diabetes Research & Care

Comunicado de imprensa: Protein supplement helps control Type 2 diabetes – Newcastle University

---

M-A | Diabetes melito gestacional e desfechos adversos na gestação.

30 Mai, 2022 | 13:26h

Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis – The BMJ

 

Comentário no Twitter

NEW research finds gestational diabetes is associated with increased odds of a range of complications for both mother and baby, including caesarean delivery, severe breathing problems, and excessive birth weight https://t.co/oyzkFxMslc

— The BMJ (@bmj_latest) May 26, 2022

 

---

Estudo randomizado | Vitamina D não previne diabetes tipo 2 em adultos de alto risco.

30 Mai, 2022 | 13:24h

Comunicado de imprensa: Vitamin D does not prevent type 2 diabetes in high risk adults, trial finds – BMJ

Estudo original: Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population – The BMJ

Editorial: Vitamin D and risk of type 2 diabetes – The BMJ

---

M-A | Terapias endoscópicas bariátricas e metabólicas e seus efeitos sobre a síndrome metabólica e a doença hepática gordurosa não alcoólica.

30 Mai, 2022 | 12:58h

Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease – A Systematic Review and Meta-Analysis – Frontiers in Medicine

---

Estudo randomizado | Efeito de uma nova intervenção com foco nas características relacionadas ao apetite do paciente sobre o índice de massa corpórea de adultos com sobrepeso ou obesidade.

30 Mai, 2022 | 12:50h

Effect of a Novel Intervention Targeting Appetitive Traits on Body Mass Index Among Adults With Overweight or Obesity: A Randomized Clinical Trial – JAMA Network Open

Comentário: New weight-loss intervention targets instinctive desire to eat – University of California – San Diego

 

Comentário no Twitter

Regulation of cues (ROC), a weight loss tx based on appetitive traits, was effective to behavioral weight loss (BWL) alone and both combined; ROC ± BWL, and BWL alone were more effective than mindfulness + social support + nutrition education. https://t.co/KN2kRBwTRu

— JAMA Network Open (@JAMANetworkOpen) May 18, 2022

 

---

Diretriz sobre intervenções para melhorar a cicatrização de úlceras no pé diabético.

27 Mai, 2022 | 13:32h

Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

---

M-A | Tratamento do diabetes tipo 2 com tirzepatida, um agonista duplo do receptor de GIP/GLP-1.

27 Mai, 2022 | 13:13h

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis – Diabetologia

Conteúdos relacionados:

Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis – Nature Medicine

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (link para o resumo – $ para o texto completo)

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes – New England Journal of Medicine (link para o resumo – $ para o texto completo)

---

Estudo de coorte | Em pacientes com doença arterial coronariana, níveis muito altos de HDL-colesterol são paradoxalmente associados com mortalidade mais alta tanto cardiovascular quanto por todas as causas.

26 Mai, 2022 | 13:12h

Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations – JAMA Cardiology (link para o resumo – $ para o texto completo)

---